These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24397721)

  • 1. Immunohistochemical evaluation of O6 -methylguanine DNA methyltransferase (MGMT) expression in 117 cases of glioblastoma.
    Miyazaki M; Nishihara H; Terasaka S; Kobayashi H; Yamaguchi S; Ito T; Kamoshima Y; Fujimoto S; Kaneko S; Katoh M; Ishii N; Mohri H; Tanino M; Kimura T; Tanaka S
    Neuropathology; 2014 Jun; 34(3):268-76. PubMed ID: 24397721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of the immunohistochemical expression of O6-methylguanine-DNA methyltransferase, P-glycoprotein, and multidrug resistance protein-1 in glioblastomas.
    Nakagawa T; Ido K; Sakuma T; Takeuchi H; Sato K; Kubota T
    Neuropathology; 2009 Aug; 29(4):379-88. PubMed ID: 19019175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide.
    Nagane M; Kobayashi K; Ohnishi A; Shimizu S; Shiokawa Y
    Jpn J Clin Oncol; 2007 Dec; 37(12):897-906. PubMed ID: 18156172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
    Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
    Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ detection of O6-methylguanine-DNA methyltransferase messenger RNA in paraffin-embedded human astrocytic tumor tissues by nested in situ RT-PCR is useful in predicting chemotherapy-resistance of tumors.
    Ohe N; Saio M; Kijima M; Tamakawa N; Suwa T; Kojima Y; Yano H; Kaku Y; Iwama T; Shinoda J; Sakai N; Takami T
    Int J Oncol; 2003 Mar; 22(3):543-9. PubMed ID: 12579307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between expression of O6-methylguanine-DNA methyltransferase, glutathione-S-transferase pi in glioblastoma and the survival of the patients treated with nimustine hydrochloride: an immunohistochemical analysis.
    Anda T; Shabani HK; Tsunoda K; Tokunaga Y; Kaminogo M; Shibata S; Hayashi T; Iseki M
    Neurol Res; 2003 Apr; 25(3):241-8. PubMed ID: 12739231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligodendrogliomas lacking O6-methylguanine-DNA-methyltransferase expression.
    Buccoliero AM; Arganini L; Ammannati F; Gallina P; Di Lorenzo N; Mennonna P; Taddei GL
    J Chemother; 2005 Jun; 17(3):321-6. PubMed ID: 16038527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study.
    Jaeckle KA; Eyre HJ; Townsend JJ; Schulman S; Knudson HM; Belanich M; Yarosh DB; Bearman SI; Giroux DJ; Schold SC
    J Clin Oncol; 1998 Oct; 16(10):3310-5. PubMed ID: 9779706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma.
    Watanabe R; Nakasu Y; Tashiro H; Mitsuya K; Ito I; Nakasu S; Nakajima T
    Brain Tumor Pathol; 2011 Apr; 28(2):127-35. PubMed ID: 21331613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [O6-methylguanine-DNA-methyltransferase (MGMT) expression in patients with glioblastoma multiforme].
    Jiménez D; Matamala JM; Chiti A; Vergara C; Tissera C; Melo R; Cartier L
    Rev Med Chil; 2018 Jan; 146(1):7-14. PubMed ID: 29806672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas.
    Brell M; Tortosa A; Verger E; Gil JM; Viñolas N; Villá S; Acebes JJ; Caral L; Pujol T; Ferrer I; Ribalta T; Graus F
    Clin Cancer Res; 2005 Jul; 11(14):5167-74. PubMed ID: 16033832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort.
    Pollack IF; Hamilton RL; Sobol RW; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL
    J Clin Oncol; 2006 Jul; 24(21):3431-7. PubMed ID: 16849758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O6-Methylguanine-DNA methyltransferase is a novel negative effector of invasion in glioblastoma multiforme.
    Chahal M; Abdulkarim B; Xu Y; Guiot MC; Easaw JC; Stifani N; Sabri S
    Mol Cancer Ther; 2012 Nov; 11(11):2440-50. PubMed ID: 22986464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MGMT promoter hypermethylation in a series of 104 glioblastomas.
    Mellai M; Caldera V; Annovazzi L; Chiò A; Lanotte M; Cassoni P; Finocchiaro G; Schiffer D
    Cancer Genomics Proteomics; 2009; 6(4):219-27. PubMed ID: 19656999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma: relationship between immunohistochemistry and methylation analysis.
    Sasai K; Nodagashira M; Nishihara H; Aoyanagi E; Wang L; Katoh M; Murata J; Ozaki Y; Ito T; Fujimoto S; Kaneko S; Nagashima K; Tanaka S
    Am J Surg Pathol; 2008 Aug; 32(8):1220-7. PubMed ID: 18580490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between the expression of O6-methylguanine-DNA methyltransferase in glioma and the survival time of patients].
    Sun YH; Zhang YZ; Wang ZC; Sun MZ; Zhao DH
    Ai Zheng; 2004 Sep; 23(9):1052-5. PubMed ID: 15363200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis.
    Dahlrot RH; Dowsett J; Fosmark S; Malmström A; Henriksson R; Boldt H; de Stricker K; Sørensen MD; Poulsen HS; Lysiak M; Söderkvist P; Rosell J; Hansen S; Kristensen BW
    Neuropathol Appl Neurobiol; 2018 Feb; 44(2):172-184. PubMed ID: 28574607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transcriptional regulation of O(6)-methylguanine-DNA methyltransferase MGMT in glioblastomas.
    Ramakrishnan V; Kushwaha D; Koay DC; Reddy H; Mao Y; Zhou L; Ng K; Zinn P; Carter B; Chen CC
    Cancer Biomark; 2011-2012; 10(3-4):185-93. PubMed ID: 22674304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas.
    Lee D; Suh YL; Park TI; Do IG; Seol HJ; Nam DH; Kim ST
    J Surg Oncol; 2013 May; 107(6):646-52. PubMed ID: 22926763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O6-methylguanine-DNA methyltransferase activity in adult gliomas: relation to patient and tumor characteristics.
    Silber JR; Bobola MS; Ghatan S; Blank A; Kolstoe DD; Berger MS
    Cancer Res; 1998 Mar; 58(5):1068-73. PubMed ID: 9500473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.